Baker Biotech Capital III (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital III (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital III (GP), LLC. Baker Biotech Capital III (GP), LLC is 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
Latest Insider Trading Transactions of Baker Biotech Capital III (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, SGEN, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 20.41 | 32,063 | 654,435 | 1,648,599 | 1.7 M to 1.6 M (-1.91 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 19.90 | 65,192 | 1,297,014 | 1,680,662 | 1.7 M to 1.7 M (-3.73 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.81 | 184 | 4,012 | 1,745,854 | 1.7 M to 1.7 M (-0.01 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.58 | 9,963 | 215,001 | 1,746,038 | 1.8 M to 1.7 M (-0.57 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.72 | 44,449 | 965,619 | 1,756,001 | 1.8 M to 1.8 M (-2.47 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.74 | 43,922 | 954,996 | 1,800,450 | 1.8 M to 1.8 M (-2.38 %) |
| May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 123,000 | 307,500 | 4,314,000 | |
| May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 2.65 | 295 | 782 | 5,103 | 4.8 K to 5.1 K (+6.14 %) |
| May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 1.79 | 2,460 | 4,403 | 4,808 | 2.3 K to 4.8 K (+104.77 %) |
| May 04 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 109.15 | 378,000 | 41,258,700 | 1,485,000 | |
| Apr 22 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 109.15 | 366,000 | 39,948,900 | 1,107,000 | |
| Apr 22 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 109.15 | 248,000 | 27,069,200 | 741,000 | |
| Apr 22 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 86,000 | 215,000 | 4,191,000 | |
| Apr 18 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 60,000 | 150,000 | 4,105,000 | |
| Apr 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 109.15 | 493,000 | 53,810,950 | 493,000 | |
| Apr 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 126,000 | 315,000 | 4,045,000 | |
| Apr 08 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 268,000 | 670,000 | 3,793,000 | |
| Apr 08 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 126,000 | 315,000 | 3,919,000 | |
| Apr 08 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 28,000 | 70,000 | 3,525,000 | |
| May 06 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.79 | 6,305 | 30,199 | 234,861 | 228.6 K to 234.9 K (+2.76 %) |
| Apr 01 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.96 | 9,617 | 47,724 | 151,797 | 142.2 K to 151.8 K (+6.76 %) |
| Apr 14 2005 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 3.57 | 1,256 | 4,484 | 1,256 | 0 to 1.3 K |
| Mar 02 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 258,000 | 645,000 | 3,497,000 | |
| Mar 02 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 117,000 | 292,500 | 3,239,000 | |
| Mar 02 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 293,000 | 732,500 | 3,122,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 116,000 | 290,000 | 2,829,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 348,000 | 870,000 | 2,713,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 163,000 | 407,500 | 2,365,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 3.02 | 2,348 | 7,090 | 2,348 | 0 to 2.3 K |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.90 | 5,276 | 25,848 | 142,180 | 136.9 K to 142.2 K (+3.85 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.81 | 2,210 | 10,638 | 136,904 | 134.7 K to 136.9 K (+1.64 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.90 | 719 | 3,523 | 134,694 | 134 K to 134.7 K (+0.54 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.96 | 63,330 | 314,085 | 133,975 | 70.6 K to 134 K (+89.65 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.99 | 46 | 230 | 70,645 | 70.6 K to 70.6 K (+0.07 %) |
Page: 1